128 related articles for article (PubMed ID: 34913802)
1. A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers.
Pi J; Xiong Y; Liu C; Liao J; Liu J; Li C; Fu W; Zhao T
J Invest Surg; 2022 May; 35(5):1186-1194. PubMed ID: 34913802
[TBL] [Abstract][Full Text] [Related]
2. Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study.
Luo Z; Jiao B; Huang T; Zhao H; He W; Bo Y; Ding Z; Zhang G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11223-11231. PubMed ID: 37355502
[TBL] [Abstract][Full Text] [Related]
3. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Fujita N; Hatakeyama S; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111
[TBL] [Abstract][Full Text] [Related]
4. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.
Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a preoperative nomogram to predict lymph node metastasis in patients with bladder urothelial carcinoma.
Ji J; Yao Y; Sun L; Yang Q; Zhang G
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10911-10923. PubMed ID: 37318590
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer.
Jiang P; Jia M; Hu J; Huang Z; Deng Y; Hu Z
Front Oncol; 2020; 10():586081. PubMed ID: 33585205
[TBL] [Abstract][Full Text] [Related]
8. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
Nakagawa T; Taguchi S; Uemura Y; Kanatani A; Ikeda M; Matsumoto A; Yoshida K; Kawai T; Nagata M; Yamada D; Komemushi Y; Suzuki M; Enomoto Y; Nishimatsu H; Ishikawa A; Nagase Y; Kondo Y; Tanaka Y; Okaneya T; Hirano Y; Shinohara M; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Urol Oncol; 2017 Jul; 35(7):457.e15-457.e21. PubMed ID: 28110856
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer.
Ding L; Deng X; Xia W; Wang K; Zhang Y; Zhang Y; Shao X; Wang J
Front Immunol; 2022; 13():1070043. PubMed ID: 36458001
[TBL] [Abstract][Full Text] [Related]
13. Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patients.
Lai S; Long X; Wu P; Liu J; Seery S; Hou H; Liu M; Li Y; Wang J
Jpn J Clin Oncol; 2021 Jul; 51(7):1132-1141. PubMed ID: 33634310
[TBL] [Abstract][Full Text] [Related]
14. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.
Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J
J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.
Liu S; Hou J; Zhang H; Wu Y; Hu M; Zhang L; Xu J; Na R; Jiang H; Ding Q
PLoS One; 2015; 10(4):e0123617. PubMed ID: 25849552
[TBL] [Abstract][Full Text] [Related]
16. [The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
Tochigi T; Sakurada Y; Aoki H; Kawamura S; Itou S; Satou I; Tateno H
Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):610-6. PubMed ID: 23120995
[TBL] [Abstract][Full Text] [Related]
17. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
19. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
20. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A
Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
